JBTM trades 14.8% below Wall Street's consensus target of $170.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes JBTM achieves its forward estimates and maintains a stable P/E multiple of 17.9x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, JBT Marel Corporation (JBTM) has a Wall Street consensus price target of $170.00, based on estimates from 2 covering analysts. With the stock currently trading at $148.05, this represents a potential upside of +14.8%. The company has a market capitalization of $7.71B.
Analyst price targets range from a low of $165.00 to a high of $175.00, representing a 6% spread in expectations. The median target of $170.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, JBTM trades at a trailing P/E of -149.5x and forward P/E of 17.9x. Analysts expect EPS to grow +159.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $91.32, with bear and bull scenarios of $57.53 and $120.32 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MIDDThe Middleby Corporation | $8.1B | $179.20 | $200.00 | +11.6% | Buy | 18.7x | 20 |
FMCFMC Corporation | $1.4B | $11.38 | $16.10 | +41.5% | Hold | 6.6x | 42 |
GEFGreif, Inc. | $3.5B | $73.87 | $75.00 | +1.5% | Hold | 19.0x | 13 |
HLIHoulihan Lokey, Inc. | $9.8B | $142.45 | $188.00 | +32.0% | Buy | 18.5x | 15 |
CECOCECO Environmental Corp. | $2.9B | $80.68 | $105.40 | +30.6% | Buy | 44.3x | 16 |
TRMKTrustmark Corporation | $2.7B | $46.55 | $45.50 | -2.3% | Hold | 11.9x | 9 |
PFGCPerformance Food Group Company | $17.9B | $113.74 | $118.80 | +4.4% | Buy | 24.7x | 25 |
TSNTyson Foods, Inc. | $20.9B | $58.75 | $73.00 | +24.3% | Buy | 14.6x | 30 |
HRLHormel Foods Corporation | $13.4B | $24.28 | $23.50 | -3.2% | Hold | 16.3x | 29 |
CAGConagra Brands, Inc. | $6.6B | $13.79 | $14.00 | +1.5% | Hold | 8.1x | 25 |
Quick answers to the most common questions about buying JBTM stock.
JBT Marel Corporation (JBTM) has a consensus 12-month price target of $170, implying 14.8% upside from $148.05. The 2 analysts covering JBTM see moderate appreciation potential.
JBTM has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $170 implies 14.8% upside from current levels.
With a forward P/E of 17.8733x, JBTM trades at a relatively low valuation. The consensus target of $170 implies 14.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $175 for JBTM, while the most conservative target is $165. The consensus of $170 represents the median expectation. Our quantitative valuation model projects a bull case target of $120 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
JBTM is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month JBTM stock forecast based on 2 Wall Street analysts shows a consensus price target of $170, with estimates ranging from $165 (bear case) to $175 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $91, with bear/bull scenarios of $58/$120.
Our quantitative valuation model calculates JBTM's fair value at $91 (base case), with a bear case of $58 and bull case of $120. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
JBTM trades at a forward P/E ratio of 17.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on JBTM, with a "Buy" consensus rating and $170 price target (14.8% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
JBTM analyst price targets range from $165 to $175, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $170 consensus represents the middle ground. Our model's $58-$120 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.